March 2004 PDF Print E-mail
Stephenson AJ, Shariat SF, Zelefsky MJ, Kattan MW, Butler EB, Teh BS, Klein EA, Kupelian PA, Roehrborn CG, Pistenmaa DA, Pacholke HD, Liauw SL, Katz MS, Leibel SA, Scardino PT, Slawin KM.
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
JAMA. 2004 Mar 17;291(11):1325-32.


John P. Neoptolemos, M.D., Deborah D. Stocken, M.Sc., Helmut Friess, M.D., Claudio Bassi, M.D. et al for the European Study Group for Pancreatic Cancer
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer.
NEJM 350:1200-1210 Mar 18, 2004 Number 12


R. Charles Coombes, M.D., Ph.D., Emma Hall, Ph.D., Lorna J. Gibson, M.Phil., Robert Paridaens, M.D., Ph.D., Jacek Jassem, M.D., Ph.D., et al for the Intergroup Exemestane Study
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer .
NEJM 350:1081-1092 Mar 11, 2004 Number 11

Koong AC, Le QT, Ho A, Fong B, Fisher G, Cho C, Ford J, Poen J, Gibbs IC, Mehta VK, Kee S, Trueblood W, Yang G, Bastidas JA.

Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer.
Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1017-21.

Prados MD, Seiferheld W, Sandler HM, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ Jr.
Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1147-52.

Geinitz H, Zimmermann FB, Thamm R, Keller M, Busch R, Molls M.
Fatigue in patients with adjuvant radiation therapy for breast cancer: long-term follow-up.
J Cancer Res Clin Oncol. 2004 Mar 6

Moore HG, Gittleman AE, Minsky BD, Wong D, Paty PB, Weiser M, Temple L, Saltz L, Shia J, Guillem JG.
Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection.
Dis Colon Rectum. 2004 Mar;47(3):279-86.
Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, Pearlman A, Maiman MA, Bell JG.
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.
Gynecol Oncol. 2004 Mar;92(3):744-51.

Wilkowski R, Thoma M, Duhmke E, Rau HG, Heinemann V.
Concurrent chemoradiotherapy with gemcitabine and cisplatin after incomplete (R1) resection of locally advanced pancreatic carcinoma.
Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):768-72.

Buyyounouski MK, Horwitz EM, Price RA, Hanlon AL, Uzzo RG, Pollack A.
Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatment.
Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):743-9.

Michalski JM, Winter K, Purdy JA, Perez CA, Ryu JK, Parliament MB, Valicenti RK, Roach M 3rd, Sandler HM, Markoe AM, Cox JD.
Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):735-42.

Rogers JW, Greven KM, McGuirt WF, Keyes JW Jr, Williams DW 3rd, Watson NE, Geisinger K, Cappellari JO.
Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?
Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):694-7.

Trotti A, Garden A, Warde P, Symonds P, Langer C, Redman R, Pajak TF, Fleming TR, Henke M, Bourhis J, Rosenthal DI, Junor E, Cmelak A, Sheehan F, Pulliam J, Devitt-Risse P, Fuchs H, Chambers M, O'Sullivan B, Ang KK.
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.
Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):674-81.

Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG.
Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
J Clin Oncol. 2004 Mar 1;22(5):872-80.

Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Uzzo RG, Hanks GE.
Prostate cancer radiotherapy dose response: an update of the fox chase experience.
J Urol. 2004 Mar;171(3):1132-6.

Rades D, Raabe A, Bajrovic A, Alberti W.
Treatment of Solitary Brain MetastasisResection Followed by Whole Brain Radiation Therapy (WBRT) and a Radiation Boost to the Metastatic Site.
Strahlenther Onkol. 2004 Mar;180(3):144-7.